1995
DOI: 10.1073/pnas.92.25.11485
|View full text |Cite
|
Sign up to set email alerts
|

Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity.

Abstract: V(D)J rearrangement is the molecular mechanism by which an almost infinite array of specific immune receptors are generated. Defects in this process result in profound immunodeficiency as is the case in the C.B-17 SCID mouse or in RAG-1 (recombination-activating gene 1) or RAG-2 deficient mice. It has recently become clear that the V(D)J recombinase most likely consists of both lymphoidspecific factors and ubiquitously expressed components of the DNA double-strand break repair pathway. The deficit in SCID mice… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
109
1

Year Published

1997
1997
2024
2024

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 137 publications
(112 citation statements)
references
References 44 publications
2
109
1
Order By: Relevance
“…It is therefore possible that a selective DNA-PK inhibitor will allow treatment of tumors that are otherwise resistant to radiotherapy and anticancer drugs. The notion that mice (Gao et al, 1998) and horses (Wiler et al, 1995;Shin et al, 1997) lacking DNA-PKcs have little apparent defects other than immunodeficiency and ionizing radiation sensitivity indicates that a specific DNA-PK inhibitor can be well tolerated in the absence of radiation. This will likely facilitate the evaluation of this class of drugs in combination with the existing cancer therapy.…”
Section: Discussionmentioning
confidence: 99%
“…It is therefore possible that a selective DNA-PK inhibitor will allow treatment of tumors that are otherwise resistant to radiotherapy and anticancer drugs. The notion that mice (Gao et al, 1998) and horses (Wiler et al, 1995;Shin et al, 1997) lacking DNA-PKcs have little apparent defects other than immunodeficiency and ionizing radiation sensitivity indicates that a specific DNA-PK inhibitor can be well tolerated in the absence of radiation. This will likely facilitate the evaluation of this class of drugs in combination with the existing cancer therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Genetic mutations in the ATM or DNA-PKcs gene result in immunodeficiency, cancer susceptibility and hypersensitivity to ionising radiation (Lavin and Shiloh, 1997;Rotman and Shiloh, 1999). However, in contrast to ATM, DNAPKcs deficiency has not been described in humans, as in lower species (Blunt et al, 1995;Wiler et al, 1995;Shin et al, 1997;Meek et al, 2001;Ding et al, 2002). In human tumour cell lines of glioblastoma origin DNA-PKcs has been shown to be important for their response to radiation (Allalunis-Turner et al, 1993).…”
mentioning
confidence: 99%
“…Naturally occurring DNA-PKcs mutations have been characterized in mice and Arabian foals (17)(18)(19); in both species, these mutations result in a severe combined immunodeficiency syndrome (Scid). The Scid phenotype results from loss of efficient DNA repair in V(D)J recombination reactions (20 -22).…”
mentioning
confidence: 99%